Inventor · disambiguated record
Jianwei Che
Also filed as: CHE JIANWEI
7 granted patents·23 pending applications·52 citations·filing 2004–2023
79Inventor score
Top patents by PatentIndex Score
30 records- 0191US8354526B2Pyrido [4, 3-D] pyrimidinone derivatives as kinase inhibitorsIRM LLC·Filed 2009·Granted Jan 15, 2013·39 cites·23 claims
- 0279US8546370B2Compounds and compositions as kinase inhibitorsOKRAM BARUN·Filed 2009·Granted Oct 1, 2013·9 cites·25 claims
- 0372US8722692B2Compounds and compositions as Syk kinase inhibitorsCHE JIANWEI·Filed 2010·Granted May 13, 2014·4 cites·23 claims
- 0460US2023339922A1Covalent egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
- 0560US2025221998A1Discovery of covalent egfr inhibitor through cysteine 775DANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
- 0659US2025074890A1Cyanopyridine and cyanopyrimidine bcl6 degradersDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 0758US2024336643A1Bifunctional compounds that degrade alk and uses thereofDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 0858US2021403460A1Inhibitors of mutant isocitrate dehydrogenases and compositions and methods thereofISOCURE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 0958US2023295137A1Covalent egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
- 1057US2024217970A1Phthalimido cereblon complex binders and transcription factor degraders and methods of useDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 1157US2024352021A1Covalent egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 1256US2024166665A1Covalent egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 1353US11149032B2Inhibitors of mutant isocitrate dehydrogenases and compositions and methods thereofISOCURE BIOSCIENCES INC·Filed 2017·Granted Oct 19, 2021·0 cites·16 claims
- 1453US10781207B2Inhibitors of mutant isocitrate dehydrogenases and compositions and methods thereofISOCURE BIOSCIENCES INC·Filed 2017·Granted Sep 22, 2020·0 cites·7 claims
- 1553US2025122210A1Small molecule inhibitors of kras g12d mutantDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 1653US2024034723A1Piperidinyl small molecule degraders of helios and methods of useDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 1753US2021101899A1Inhibitors of mutant isocitrate dehydrogenases and compositions and methods thereofISOCURE BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1853US2023158157A1Potent and selective degraders of alkDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 1952US2023192644A1Piperidine-2,6-diones as small molecule degraders of helios and methods of useDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 2052US2023002397A1Small molecule degraders of helios and metods of useDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 2152US2024360104A1Transcriptional enhanced associated domain (tead) transcription factor inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 2250US11771702B2Agonists of PPAR-δGOLDBLUM AMIRAM·Filed 2019·Granted Oct 3, 2023·0 cites·19 claims
- 2350US2024124406A1Inhibitors of transcriptional enhanced associate domain (tead) and uses thereofDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 2450US2023192607A1Transcriptional enhanced associate domain (tead) transcription factor inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 2550US2022227734A1Degraders of cyclin-dependent kinase 12 (cdk12) and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 2649US2023271932A1Small molecule covalent activators of ucp1DANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 2743US2005214788A1Method and system for clustering and rescaling for molecular analysisIRM LLC·Filed 2004·Application pending·0 cites
- 2835US10422007B2Markers associated with Wnt inhibitorsCHE JIANWEI·Filed 2014·Granted Sep 24, 2019·0 cites·6 claims
- 2935US2020140444A1Inhibitors of mutant isocitrate dehydrogenases and compositions and methods thereofISOCURE BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 3034US2011053897A1Compounds and compositions as syk kinase inhibitorsIRM LLC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jianwei Che files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →